Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.32bn	n/a	n/a
MSBMesoblast	AU$2.65bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.27bn	n/a	n/a
PYCPYC Therapeutics	AU$1.24bn	n/a	n/a
RACRacura Oncology	AU$511.72m	n/a	n/a
CGSCogstate	AU$370.56m	24.88	0.86%
TTXTetratherix	AU$242.60m	n/a	n/a
DXBDimerix	AU$195.13m	n/a	n/a
PEBPacific Edge	NZ$186.03m	n/a	n/a
NYRNyrada	AU$121.63m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$115.70m	n/a	n/a
ACWActinogen Medical	AU$114.73m	n/a	n/a
BXNBioxyne	AU$113.50m	13.21	n/a
ILAIsland Pharmaceuticals	AU$102.24m	n/a	n/a
ALAArovella Therapeutics	AU$85.28m	n/a	n/a
ATHAlterity Therapeutics	AU$76.13m	n/a	n/a
IMMImmutep	AU$73.69m	n/a	n/a
LTPLtr Pharma	AU$71.75m	n/a	n/a
CYPCynata Therapeutics	AU$68.86m	n/a	n/a
RHYRhythm Biosciences	AU$67.40m	n/a	n/a